Cutaneous Manifestations in End-Stage Renal Disease (ESRD)

Amira Suryani Rahmatika (1), Trisniartami Setyaningrum (2), Sawitri Sawitri (3), Evy Ervianti (4), Damayanti Damayanti (5)
(1) Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya – Indonesia, Indonesia,
(2) , Indonesia,
(3) , Indonesia,
(4) , Indonesia,
(5) , Indonesia


Skin can reflect systemic conditions due to abnormalities in internal organs, including kidney disorders. Cutaneous manifestations are common in patients with end-stage renal disease (ESRD). It can be severe and negatively impact a patient's quality of life. Clinicians can effectively manage ESRD by closely examining the patient's skin and nails, improving the patient's quality of life, and reducing mortality and morbidity. Clinicians can be more aware of ESRD by examining the patient's skin and nails closely so proper management can be performed and the patient's quality of life can be improved. This review aims to increase understanding of common cutaneous manifestations in ESRD for early recognition and better management.  Cutaneous manifestations in ESRD are divided into specific and nonspecific manifestations. Specific manifestations include acquired perforating dermatosis (APD), bullous disease (porphyria cutanea tarda and pseudoporphyria), metastatic calcification (calcinosis cutis and calcific uremic arteriolopathy), and nephrogenic systemic fibrosis. Nonspecific manifestations include pruritus, xerosis, skin pigmentation changes, nail disorders, purpura, hair disorders, oral mucosal changes, skin infections, and other skin manifestations. These manifestations range from benign and asymptomatic to serious conditions that negatively impact life quality. In conclusion, Early detection and treatment of cutaneous manifestations in patients with ESRD are crucial for reducing morbidity and mortality and also improving patients' quality of life.

Full text article

Generated from XML file


Adejumo, O. et al. (2019) ‘Skin changes and dermatological life quality index in chronic kidney disease patients in a tertiary hospital in Southern Nigeria’, Nigerian Journal of Clinical Practice, 22(2), pp. 245–250. doi 10.4103/njcp.njcp_270_18.

Anderson, K. and Gou, E. (2019) ‘The Porphyrias’, in Amagai, M. and Kang, S. (eds) Fitzpatrick’s Dermatology Vol.2. 9th edn. United States: McGraw Hiill Education, pp. 2235–2242.

Azimi, E., Lerner, E. A., and Elmariah, S. B. (2015) ‘Pruritus in Chronic Kidney Disease’, in Dermatological Manifestations of Kidney Disease. New York: Springer Science+Business Media, p. 81. doi: 10.1007/978-1-4939-2395-3_7.

Chanda, G. M., Chintagunta, S. R., and Arakkal, G. (2017) ‘Dermatological manifestations in chronic renal failure patients with and without hemodialysis : A study at a tertiary care centre’, Journal of Dr. NTR University of Health Sciences, 6, pp. 8–14. doi: 10.4103/JDRNTRUHS.JDRNTRUHS.

Charu, B. and Anshul, V. (2020) ‘Dermatological Manifestations in Patients of Chronic Kidney Disease (CKD)’, Medico-Legal Update, 20(4), pp. 1275–1278. doi: 10.37506/mlu.v20i4.2004.

Fauziyati, A. (2017) ‘Global challenge of early detection and management of Chronic Kidney Disease’, Indonesia Journal of Medicine and Health, 8(1), pp. 1–2. doi: 10.20885/JKKI.Vol8.Iss1.art1.

Forrestel, A. K. and Micheletti, R. G. (2019) ‘Skin Manifestations of Internal Organ Disorders’,

in Fitzpatrick’s Dermatology Vol.2. 9th edn. McGraw Hiill Education, pp. 2436–2439.

Galperin, T. A., Cronin, A. J., and Leslie, K. S. (2014) ‘Cutaneous manifestations of ESRD’, Clinical Journal of the American Society of Nephrology, 9(1), pp. 201–218. doi: 10.2215/CJN.05900513.

Gandimohan, R. and Prabhakaran, A. (2019) ‘Dermatological Manifestations in Ned Stage Renal Disease’, IOSR Journal of Dental and Medical Sciences, 18(3), pp. 10–15. doi: 10.9790/0853-1803081015.

Garrido, P. M. et al. (2020) ‘Acquired perforating dermatosis: clinicopathologic study of a 10-

year period at a tertiary teaching hospital’, International Journal of Dermatology, 59(4), pp. 445–450. doi: 10.1111/ijd.14760.

Gilbert, L. et al. (2021) ‘Prevalence and risk factors associated with HIV and syphilis co- infection in the African Cohort Study: a cross-sectional study’, BMC Infectious Diseases, 21(1), pp. 1–7. doi: 10.1186/s12879-021-06668-6.

Gnanaserkan, R. et al. (2020) ‘Cutaneous manifestations in patients with chronic renal failure on hemodialysis’, / IP Indian Journal of Clinical and Experimental Dermatology, 6(2), pp. 168–173. doi:

Kim, H. S. et al. (2020) ‘Successful Treatment of Acquired Perforating Dermatosis in a Peritoneal Dialysis Patient Using Oral Isotretinoin’, The Korean Journal of Medicine, 95(3), pp. 201–204. doi: 10.3904/kjm.2020.95.3.201.

Kuypers, D. R. J. (2009) ‘Skin problems in chronic kidney disease’, Nature Clinical Practice Nephrology, 5(3), pp. 157–170. doi: 10.1038/ncpneph1040.

Laporan Nasional RISKESDAS 2018 (2018). Jakarta. Available at: 2018_1274.pdf.

Lima, A. L. et al. (2017) ‘Cutaneous Manifestations of Diabetes Mellitus: A Review’, American Journal of Clinical Dermatology, 18(4), pp. 541–553. doi: 10.1007/s40257-017- 0275-z.

Lukács, J., Schliemann, S., and Elsner, P. (2018) ‘Treatment of acquired reactive perforating

dermatosis - a systematic review’, Journal der Deutschen Dermatologischen Gesellschaft

= Journal of the German Society of Dermatology : JDDG, 16(7), pp. 825–842. doi: 10.1111/ddg.13561.

Maiberger, J and Nunley, M. P. (2017) ‘Renal Disease and The Skin’, in Callen, Jeffrey P. Jorizzo, J. L. (ed.) Dermatological Signs of Systemic Disease. 5th edn. Elsevier Inc, pp. 323–329.

Malkud, S., Dyavannanavar, V., and Varala, S. (2020) ‘Cutaneous manifestations in patients with chronic kidney disease on hemodialysis’, Journal of Pakistan Association of Dermatologists, 30(3), pp. 490–496.

Mardiana, N. and Aditiawardana (2015) ‘Penyakit Ginjal Kronis’, in Tjokroprawiro, A. (ed.)

Buku Ajar Ilmu Penyakit Dalam. 2nd edn. Surabaya: Airlangga University Press.

Maskey, A., Kumar, A., and Shrestha, R. (2020) ‘Study of Cutaneous Manifestations in End Stage Kidney Disease Undergoing Hemodialysis’, Nepal Journal of Dermatology, Venereology & Leprology, 18(1), pp. 37–43. doi: 10.3126/njdvl.v18i1.29568.

Moon, S. J. et al. (2009) ‘The impact of dialysis modality on skin hyperpigmentation in haemodialysis patients’, Nephrology Dialysis Transplantation, 24(9), pp. 2803–2809. doi: 10.1093/ndt/gfp143.

Pallet, N. et al. (2018) ‘Porphyria and kidney diseases’, Clinical Kidney Journal, 11(2), pp.

–197. doi: 10.1093/ckj/sfx146.

Prodjosudjadi, W. and Suhardjono, A. (2009) ‘End-Stage Renal Disease in Indonesia : Treatment Development’, Spring, 19(December), pp. 33–36.

Raiesifar, Z. et al. (2018) ‘Assessment of Skin Manifestations in End-Stage Renal Disease Patients Undergoing Hemodialysis in Shahid Beheshti Hospital of Abadan and Vali-e-Asr Hospital of Khorramshahr’, Jundishapur Journal of Chronic Disease Care, In Press(In Press), pp. 6–10. doi: 10.5812/jjcdc.83381.

Raja, S. M. (2021) ‘Chronic kidney disease entertained from Lindsay’s nails: A case report and literature review’, Clinical Case Reports, 9(7), pp. 10–12. doi: 10.1002/ccr3.4426.

Raspha, R. S. et al. (2018) ‘Mucocutaneous Manifestations in Patients with Chronic Kidney

Disease: A Cross-sectional Study’, Indian Dermatology Online Journal, 9(9), pp. 20–26.

Rehman, I. U. and Khan, T. M. (2020) ‘Epidemiology of Chronic Kidney Diseases (CKD) in Malaysia and Pakistan, Pathophysiology of CKD-Associated Pruritus and Other CKD- Associated Dermatological Disorders’, Progress In Microbes & Molecular Biology, 3(1), pp. 1–8. doi: 10.36877/pmmb.a0000063.

Sabban, E. N. C. (2018) Dermatoses most frequently related to diabetes mellitus, Dermatology and Diabetes. doi: 10.1007/978-3-319-72475-1_11.

Sanai, M. et al. (2010) ‘Dermatologic manifestations in patients of renal disease on hemodialysis’, Journal of Pakistan Association of Dermatologists, 20, pp. 163–168.

Sartika, D., Putra, I. B. and Yosi, A. (2019) ‘Profile of Skin Manifestations in Chronic Kidney Failure Patients with Hemodialysis and Non-Hemodialysis in Universitas Sumatera Utara Hospital Medan’, International Journal of Scientific and Research Publications (IJSRP), 9(10), p. p9465. doi: 10.29322/ijsrp.9.10.2019.p9465.

Sartori-Valinotti, J. C. and Davis, M. (2015) ‘Calciphylaxis’, in Nunley, J. R. and Lerma, E.

V. (eds) Manifestations of Kidney Disease. New York: Springer Science+Business Media, pp. 101–111.

Shemer, A., Sakka, N. and Daniel, C. R. (2015) ‘Nail Diseases Among Renal Patients’, in Nunley, J. R. and Lerma, E. V. (eds) Dermatological Manifestations of Kidney Disease. New York: Springer Science+Business Media, pp. 150–151. doi: 10.1007/978-1-4939- 2395-3_14.

Singal, A. K. (2019) ‘Porphyria cutanea tarda: Recent update’, Molecular Genetics and Metabolism, 128(3), pp. 271–281. doi: 10.1016/j.ymgme.2019.01.004.

Verduzco, H. A. and Shirazian, S. (2020) ‘CKD-Associated Pruritus: New Insights Into Diagnosis, Pathogenesis, and Management’, Kidney International Reports, 5(9), pp. 1387– 1402. doi: 10.1016/j.ekir.2020.04.027.

Wang, M. et al. (2020) ‘Clinical characteristics and prognosis of acquired perforating dermatosis: A case report’, Experimental and Therapeutic Medicine, pp. 3634–3640. doi: 10.3892/etm.2020.8651.

Wick, M. R. (2017) ‘Bullous, pseudobullous, & pustular dermatoses’, Seminars in Diagnostic Pathology, 34(3), pp. 250–260. doi: 10.1053/j.semdp.2016.12.001.

Wu, C. M. et al. (2015) ‘Xerosis’, in Dermatological Manifestations of Kidney Disease, pp.



Amira Suryani Rahmatika (Primary Contact)
Trisniartami Setyaningrum
Sawitri Sawitri
Evy Ervianti
Damayanti Damayanti
Rahmatika, A. S., Setyaningrum, T., Sawitri, S., Ervianti, E., & Damayanti, D. (2024). Cutaneous Manifestations in End-Stage Renal Disease (ESRD). Qanun Medika - Medical Journal Faculty of Medicine Muhammadiyah Surabaya, 8(01).

Article Details

No Related Submission Found